Back to News
Market Impact: 0.1
Addex Therapeutics Ltd Increases Issued Share Capital to Create Treasury Shares
Source: Nasdaq
Company Fundamentals
Addex Therapeutics issued 93,000,000 new registered shares with a nominal value of CHF 0.01 each from its capital band. The shares were fully subscribed by Addex Pharma S.A., the company’s wholly owned subsidiary; the article text is truncated before completing the listing details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- PC chip plunge wipes out a quarter of Intel’s value
- Intel plunges on a major guidance miss. What went wrong — and how to proceed
- FedEx Freight delivers a much-needed quarterly beat. Where we stand on shares now